Trump’s posting of a video portraying Barack and Michelle Obama as apes is one of his more glaring miscalculations, which have given Democrats an opening to halt a steady erosion of support among ...

The action in stocks on Thursday showed just how quickly simmering concerns in one corner of the market can boil over into a large-scale rout. Back To Top ...

The S&P 500 index fell into negative territory for the year on Thursday, while Wall Street’s “fear gauge” hit a 2026 high. - MarketWatch photo illustration/Getty Images, iStockphoto The action in ...

It’s not simply enough to sign up new clients, RIAs need to keep them as well. And that means making sure they accommodate client needs in house whenever they can, lest they be tempted away by a ...

You might be able to trade in a car with negative equity, but it doesn’t always make sense Written By Written by Staff Loans Writer, Buy Side Emily Sherman is a staff loans writer for Buy Side, ...

Kevin Stefanski took the Atlanta Falcons head coaching job on Saturday night and he's already started putting together his staff. According to NFL Network insider Mike Garafolo, the Falcons are ...

For the first time in decades, net migration for the United States was likely negative in 2025, and the trend could continue amid President Donald Trump's aggressive immigration enforcement actions, ...

T-Mobile has a new BOGO offer that gives you a free second line when you add a new line to your account. The new promo works with select plans, including the Experience More and Beyond plan and a few ...

Number enthusiasts may be looking to the new year with a touch of melancholy. Another perfect square like 2025 (45 2 = 2,025) won’t occur again until 2116 (46 2 = 2,116). The year 2027 will be a prime ...

Adding tucatinib to standard first-line maintenance therapy in patients with HER2-positive metastatic breast cancer led to a clinically meaningful delay in disease progression, regardless of the ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular lymphoma. The EPCORE FL-1 trial results show a 79% progression-free ...